Literature DB >> 16278292

In smooth muscle, FK506-binding protein modulates IP3 receptor-evoked Ca2+ release by mTOR and calcineurin.

Debbi MacMillan1, Susan Currie, Karen N Bradley, Thomas C Muir, John G McCarron.   

Abstract

Ca2+ release from the sarcoplasmic reticulum (SR) by the IP3 receptors (IP3Rs) crucially regulates diverse cell signalling processes from reproduction to apoptosis. Release from the IP3R may be modulated by endogenous proteins associated with the receptor, such as the 12 kDa FK506-binding protein (FKBP12), either directly or indirectly by inhibition of the phosphatase calcineurin. Here, we report that, in addition to calcineurin, FKPBs modulate release through the mammalian target of rapamycin (mTOR), a kinase that potentiates Ca2+ release from the IP3R in smooth muscle. The presence of FKBP12 was confirmed in colonic myocytes and co-immunoprecipitated with the IP3R. In aortic smooth muscle, however, although present, FKBP12 did not co-immunoprecipitate with IP3R. In voltage-clamped single colonic myocytes rapamycin, which together with FKBP12 inhibits mTOR (but not calcineurin), decreased the rise in cytosolic Ca2+ concentration ([Ca2+]c) evoked by IP3R activation (by photolysis of caged IP3), without decreasing the SR luminal Ca2+ concentration ([Ca2+]l) as did the mTOR inhibitors RAD001 and LY294002. However, FK506, which with FKBP12 inhibits calcineurin (but not mTOR), potentiated the IP3-evoked [Ca2+]c increase. This potentiation was due to the inhibition of calcineurin; it was mimicked by the phosphatase inhibitors cypermethrin and okadaic acid. The latter two inhibitors also prevented the FK506-evoked increase as did a calcineurin inhibitory peptide (CiP). In aortic smooth muscle, where FKBP12 was not associated with IP3R, the IP3-mediated Ca2+ release was unaffected by FK506 or rapamycin. Together, these results suggest that FKBP12 has little direct effect on IP3-mediated Ca2+ release, even though it is associated with IP3R in colonic myocytes. However, FKBP12 might indirectly modulate Ca2+ release through two effector proteins: (1) mTOR, which potentiates and (2) calcineurin, which inhibits Ca2+ release from IP3R in smooth muscle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16278292     DOI: 10.1242/jcs.02657

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  25 in total

Review 1.  Inositol trisphosphate receptors in smooth muscle cells.

Authors:  Damodaran Narayanan; Adebowale Adebiyi; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

Review 2.  Inositol trisphosphate receptor Ca2+ release channels.

Authors:  J Kevin Foskett; Carl White; King-Ho Cheung; Don-On Daniel Mak
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

Review 3.  Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation.

Authors:  Veerle Vanderheyden; Benoit Devogelaere; Ludwig Missiaen; Humbert De Smedt; Geert Bultynck; Jan B Parys
Journal:  Biochim Biophys Acta       Date:  2008-12-16

Review 4.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

5.  The phospholipase C inhibitor U-73122 inhibits Ca(2+) release from the intracellular sarcoplasmic reticulum Ca(2+) store by inhibiting Ca(2+) pumps in smooth muscle.

Authors:  D Macmillan; J G McCarron
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

6.  Calcineurin/Nfat signaling is required for perinatal lung maturation and function.

Authors:  Vrushank Davé; Tawanna Childs; Yan Xu; Machiko Ikegami; Valérie Besnard; Yutaka Maeda; Susan E Wert; Joel R Neilson; Gerald R Crabtree; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2006-09-21       Impact factor: 14.808

Review 7.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

8.  Regulation by FK506 and rapamycin of Ca2+ release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR.

Authors:  D MacMillan; J G McCarron
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

9.  Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis.

Authors:  Micah J Drummond; Christopher S Fry; Erin L Glynn; Hans C Dreyer; Shaheen Dhanani; Kyle L Timmerman; Elena Volpi; Blake B Rasmussen
Journal:  J Physiol       Date:  2009-02-02       Impact factor: 5.182

10.  Proteomics reveals potential non-neuronal cholinergic receptor-effectors in endothelial cells.

Authors:  Yuan-yuan Zhang; Wei Shen; Lian-cheng Zhang; Zhi-yuan Pan; Chao-liang Long; Wen-yu Cui; Yan-fang Zhang; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2014-08-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.